JP2013518046A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013518046A5 JP2013518046A5 JP2012550116A JP2012550116A JP2013518046A5 JP 2013518046 A5 JP2013518046 A5 JP 2013518046A5 JP 2012550116 A JP2012550116 A JP 2012550116A JP 2012550116 A JP2012550116 A JP 2012550116A JP 2013518046 A5 JP2013518046 A5 JP 2013518046A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- dichloro
- pyrimidine
- methyl
- oxadiazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 3-chloro-4-trifluoromethoxyphenyl Chemical group 0.000 claims description 172
- 239000000126 substance Substances 0.000 claims description 29
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 22
- BIGWXAGEQONZGD-UHFFFAOYSA-N 2h-oxadiazol-5-one Chemical compound O=C1C=NNO1 BIGWXAGEQONZGD-UHFFFAOYSA-N 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 20
- 125000005843 halogen group Chemical group 0.000 claims description 18
- 150000005829 chemical entities Chemical class 0.000 claims description 13
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 12
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 208000035475 disorder Diseases 0.000 claims description 9
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 6
- 108010033242 Kynurenine 3-monooxygenase Proteins 0.000 claims description 6
- 102100037652 Kynurenine 3-monooxygenase Human genes 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 125000001072 heteroaryl group Chemical group 0.000 claims description 6
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 6
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 claims description 6
- 125000004353 pyrazol-1-yl group Chemical group [H]C1=NN(*)C([H])=C1[H] 0.000 claims description 6
- 159000000000 sodium salts Chemical class 0.000 claims description 6
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 5
- 150000002431 hydrogen Chemical class 0.000 claims description 5
- 230000001404 mediated effect Effects 0.000 claims description 5
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 4
- MTOCMLGOPYERKW-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-(2h-tetrazol-5-yl)pyrimidine Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(C=2NN=NN=2)=NC=N1 MTOCMLGOPYERKW-UHFFFAOYSA-N 0.000 claims description 4
- SKUQIZNIGNTGFZ-UHFFFAOYSA-N 4-(3,4-difluorophenyl)-6-(2h-tetrazol-5-yl)pyrimidine Chemical compound C1=C(F)C(F)=CC=C1C1=CC(C=2NN=NN=2)=NC=N1 SKUQIZNIGNTGFZ-UHFFFAOYSA-N 0.000 claims description 4
- WNENMQUGXZYTTO-UHFFFAOYSA-N 4-(3-chloro-4-fluorophenyl)-6-(2h-tetrazol-5-yl)pyrimidine Chemical compound C1=C(Cl)C(F)=CC=C1C1=CC(C=2NN=NN=2)=NC=N1 WNENMQUGXZYTTO-UHFFFAOYSA-N 0.000 claims description 4
- 208000024827 Alzheimer disease Diseases 0.000 claims description 4
- 208000023105 Huntington disease Diseases 0.000 claims description 4
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 claims description 4
- 230000000626 neurodegenerative effect Effects 0.000 claims description 4
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 239000000651 prodrug Substances 0.000 claims description 4
- 229940002612 prodrug Drugs 0.000 claims description 4
- 125000004523 tetrazol-1-yl group Chemical group N1(N=NN=C1)* 0.000 claims description 4
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- OKEPDOSLTPWNMJ-UHFFFAOYSA-N 1-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-3-methylimidazol-2-one Chemical compound O=C1N(C)C=CN1C1=CC(C=2C=C(Cl)C(Cl)=CC=2)=NC=N1 OKEPDOSLTPWNMJ-UHFFFAOYSA-N 0.000 claims description 2
- RIFCBJMQUMYQHM-UHFFFAOYSA-N 2-[3-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-1,2,4-oxadiazol-5-yl]-n,n-dimethylethanamine Chemical compound O1C(CCN(C)C)=NC(C=2N=CN=C(C=2)C=2C=C(Cl)C(Cl)=CC=2)=N1 RIFCBJMQUMYQHM-UHFFFAOYSA-N 0.000 claims description 2
- ROSKCKKWUAUBPC-UHFFFAOYSA-N 2-[6-(3,4-dichlorophenyl)-2-methylpyrimidin-4-yl]-4-methyl-1,3-oxazole Chemical compound CC1=COC(C=2N=C(C)N=C(C=2)C=2C=C(Cl)C(Cl)=CC=2)=N1 ROSKCKKWUAUBPC-UHFFFAOYSA-N 0.000 claims description 2
- KGMUYOCFDSQXAE-UHFFFAOYSA-N 2-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-1,3-oxazole Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(C=2OC=CN=2)=NC=N1 KGMUYOCFDSQXAE-UHFFFAOYSA-N 0.000 claims description 2
- UZUWTIHQPXDNIC-UHFFFAOYSA-N 2-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-1,3-thiazole Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(C=2SC=CN=2)=NC=N1 UZUWTIHQPXDNIC-UHFFFAOYSA-N 0.000 claims description 2
- JMGZKBUMZTWCTN-UHFFFAOYSA-N 2-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-1h-benzimidazole Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(C=2NC3=CC=CC=C3N=2)=NC=N1 JMGZKBUMZTWCTN-UHFFFAOYSA-N 0.000 claims description 2
- LNRYOGXIUGDXCK-UHFFFAOYSA-N 2-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-4-methyl-1,3-oxazole Chemical compound CC1=COC(C=2N=CN=C(C=2)C=2C=C(Cl)C(Cl)=CC=2)=N1 LNRYOGXIUGDXCK-UHFFFAOYSA-N 0.000 claims description 2
- AFGXONWEIZLGHJ-UHFFFAOYSA-N 2-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-5-methyl-1h-pyrazol-3-one Chemical compound N1C(C)=CC(=O)N1C1=CC(C=2C=C(Cl)C(Cl)=CC=2)=NC=N1 AFGXONWEIZLGHJ-UHFFFAOYSA-N 0.000 claims description 2
- WDLSNFQTFQDMLE-UHFFFAOYSA-N 2-[6-(3-chlorophenyl)pyrimidin-4-yl]-1,3-benzoxazole Chemical compound ClC1=CC=CC(C=2N=CN=C(C=2)C=2OC3=CC=CC=C3N=2)=C1 WDLSNFQTFQDMLE-UHFFFAOYSA-N 0.000 claims description 2
- DIQUOHCUSXJTGE-UHFFFAOYSA-N 2-[6-(3-chlorophenyl)pyrimidin-4-yl]-1-methylbenzimidazole Chemical compound N=1C2=CC=CC=C2N(C)C=1C(N=CN=1)=CC=1C1=CC=CC(Cl)=C1 DIQUOHCUSXJTGE-UHFFFAOYSA-N 0.000 claims description 2
- KDPUXHLJFAMDMJ-UHFFFAOYSA-N 2-[6-(3-chlorophenyl)pyrimidin-4-yl]-1h-benzimidazole Chemical compound ClC1=CC=CC(C=2N=CN=C(C=2)C=2NC3=CC=CC=C3N=2)=C1 KDPUXHLJFAMDMJ-UHFFFAOYSA-N 0.000 claims description 2
- HQHXJSFDZSMZLZ-UHFFFAOYSA-N 2-[6-(3-chlorophenyl)pyrimidin-4-yl]-4-methyl-1,3-oxazole Chemical compound CC1=COC(C=2N=CN=C(C=2)C=2C=C(Cl)C=CC=2)=N1 HQHXJSFDZSMZLZ-UHFFFAOYSA-N 0.000 claims description 2
- ZAOGPGHFSWAZTM-UHFFFAOYSA-N 2-[6-(3-chlorophenyl)pyrimidin-4-yl]-5,6-difluoro-1h-benzimidazole Chemical compound N1C=2C=C(F)C(F)=CC=2N=C1C(N=CN=1)=CC=1C1=CC=CC(Cl)=C1 ZAOGPGHFSWAZTM-UHFFFAOYSA-N 0.000 claims description 2
- JUVYRFJXVZHIFC-UHFFFAOYSA-N 2-[6-(3-chlorophenyl)pyrimidin-4-yl]-6-fluoro-1h-benzimidazole Chemical compound N=1C2=CC(F)=CC=C2NC=1C(N=CN=1)=CC=1C1=CC=CC(Cl)=C1 JUVYRFJXVZHIFC-UHFFFAOYSA-N 0.000 claims description 2
- VSHASHJYPUERGY-UHFFFAOYSA-N 3-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-1h-imidazol-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(N2C(NC=C2)=O)=NC=N1 VSHASHJYPUERGY-UHFFFAOYSA-N 0.000 claims description 2
- MSYIWJXURWRDKT-UHFFFAOYSA-N 3-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-2h-1,2,4-oxadiazole-5-thione Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(C=2NC(=S)ON=2)=NC=N1 MSYIWJXURWRDKT-UHFFFAOYSA-N 0.000 claims description 2
- DJPHEZULAHNZAL-UHFFFAOYSA-N 3-pyrimidin-2-yl-2H-oxadiazole Chemical compound O1NN(C=C1)C1=NC=CC=N1 DJPHEZULAHNZAL-UHFFFAOYSA-N 0.000 claims description 2
- ZNKZDGFSYSPQCQ-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-(1,2,4-triazol-1-yl)pyrimidine Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(N2N=CN=C2)=NC=N1 ZNKZDGFSYSPQCQ-UHFFFAOYSA-N 0.000 claims description 2
- SCAIUCPQLBSMDG-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-(1-methyltetrazol-5-yl)pyrimidine Chemical compound CN1N=NN=C1C1=CC(C=2C=C(Cl)C(Cl)=CC=2)=NC=N1 SCAIUCPQLBSMDG-UHFFFAOYSA-N 0.000 claims description 2
- JIRSMOUXSFIZTD-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-(1h-1,2,4-triazol-5-yl)pyrimidine Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(C=2NC=NN=2)=NC=N1 JIRSMOUXSFIZTD-UHFFFAOYSA-N 0.000 claims description 2
- FCHVNBZJVNRUCR-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-(1h-imidazol-2-yl)pyrimidine Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(C=2NC=CN=2)=NC=N1 FCHVNBZJVNRUCR-UHFFFAOYSA-N 0.000 claims description 2
- LNXBAFBGQULGSU-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-(1h-pyrazol-5-yl)pyrimidine Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(C2=NNC=C2)=NC=N1 LNXBAFBGQULGSU-UHFFFAOYSA-N 0.000 claims description 2
- IYXFPLVXCRLSKZ-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-(2-methyltetrazol-5-yl)pyrimidine Chemical compound CN1N=NC(C=2N=CN=C(C=2)C=2C=C(Cl)C(Cl)=CC=2)=N1 IYXFPLVXCRLSKZ-UHFFFAOYSA-N 0.000 claims description 2
- ZBHJOTQYFIFNDV-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-(4,5-dihydro-1h-imidazol-2-yl)pyrimidine Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(C=2NCCN=2)=NC=N1 ZBHJOTQYFIFNDV-UHFFFAOYSA-N 0.000 claims description 2
- SZAOZTRJZVLXLO-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-(5-fluoropyridin-2-yl)pyrimidine Chemical compound N1=CC(F)=CC=C1C1=CC(C=2C=C(Cl)C(Cl)=CC=2)=NC=N1 SZAOZTRJZVLXLO-UHFFFAOYSA-N 0.000 claims description 2
- WSFAFIDQMPKXSL-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-(5-methyl-1h-1,2,4-triazol-3-yl)pyrimidine Chemical compound N1C(C)=NN=C1C1=CC(C=2C=C(Cl)C(Cl)=CC=2)=NC=N1 WSFAFIDQMPKXSL-UHFFFAOYSA-N 0.000 claims description 2
- YMUUSKWZBOGGDX-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-(5-methyl-1h-imidazol-2-yl)pyrimidine Chemical compound CC1=CNC(C=2N=CN=C(C=2)C=2C=C(Cl)C(Cl)=CC=2)=N1 YMUUSKWZBOGGDX-UHFFFAOYSA-N 0.000 claims description 2
- PYCPSMXEPSFEJE-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-[3-(trifluoromethyl)pyrazol-1-yl]pyrimidine Chemical compound N1=C(C(F)(F)F)C=CN1C1=CC(C=2C=C(Cl)C(Cl)=CC=2)=NC=N1 PYCPSMXEPSFEJE-UHFFFAOYSA-N 0.000 claims description 2
- ALWHQBOIACGJGE-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-[4-(trifluoromethyl)imidazol-1-yl]pyrimidine Chemical compound C1=NC(C(F)(F)F)=CN1C1=CC(C=2C=C(Cl)C(Cl)=CC=2)=NC=N1 ALWHQBOIACGJGE-UHFFFAOYSA-N 0.000 claims description 2
- PURBNGDJUSAPDH-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-imidazol-1-ylpyrimidine Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(N2C=NC=C2)=NC=N1 PURBNGDJUSAPDH-UHFFFAOYSA-N 0.000 claims description 2
- QKDPTHAYQCPXSV-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-6-pyrazol-1-ylpyrimidine Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(N2N=CC=C2)=NC=N1 QKDPTHAYQCPXSV-UHFFFAOYSA-N 0.000 claims description 2
- AEWCHHBGHBDHET-UHFFFAOYSA-N 4-(3-chloro-4-propan-2-yloxyphenyl)-6-(2h-tetrazol-5-yl)pyrimidine Chemical compound C1=C(Cl)C(OC(C)C)=CC=C1C1=CC(C=2NN=NN=2)=NC=N1 AEWCHHBGHBDHET-UHFFFAOYSA-N 0.000 claims description 2
- UGYNJZXCCMRSAY-UHFFFAOYSA-N 4-(3-chlorophenyl)-6-(1,2,4-triazol-1-yl)pyrimidine Chemical compound ClC1=CC=CC(C=2N=CN=C(C=2)N2N=CN=C2)=C1 UGYNJZXCCMRSAY-UHFFFAOYSA-N 0.000 claims description 2
- WWGQYSXKRDZEQL-UHFFFAOYSA-N 4-(3-chlorophenyl)-6-(1-methyltetrazol-5-yl)pyrimidine Chemical compound CN1N=NN=C1C1=CC(C=2C=C(Cl)C=CC=2)=NC=N1 WWGQYSXKRDZEQL-UHFFFAOYSA-N 0.000 claims description 2
- LGGGIVRSZVEHDF-UHFFFAOYSA-N 4-(3-chlorophenyl)-6-(1h-1,2,4-triazol-5-yl)pyrimidine Chemical compound ClC1=CC=CC(C=2N=CN=C(C=2)C=2NC=NN=2)=C1 LGGGIVRSZVEHDF-UHFFFAOYSA-N 0.000 claims description 2
- LRAVNVHTOASBPS-UHFFFAOYSA-N 4-(3-chlorophenyl)-6-(2-methyltetrazol-5-yl)pyrimidine Chemical compound CN1N=NC(C=2N=CN=C(C=2)C=2C=C(Cl)C=CC=2)=N1 LRAVNVHTOASBPS-UHFFFAOYSA-N 0.000 claims description 2
- KRYPSLGAMUHGTE-UHFFFAOYSA-N 4-(3-chlorophenyl)-6-(2h-tetrazol-5-yl)pyrimidine Chemical compound ClC1=CC=CC(C=2N=CN=C(C=2)C=2NN=NN=2)=C1 KRYPSLGAMUHGTE-UHFFFAOYSA-N 0.000 claims description 2
- NZHPCOKTLUVIDD-UHFFFAOYSA-N 4-(3-chlorophenyl)-6-(tetrazol-1-yl)pyrimidine Chemical compound ClC1=CC=CC(C=2N=CN=C(C=2)N2N=NN=C2)=C1 NZHPCOKTLUVIDD-UHFFFAOYSA-N 0.000 claims description 2
- DAROHEOKVSJSFA-UHFFFAOYSA-N 4-(3-chlorophenyl)-6-imidazol-1-ylpyrimidine Chemical compound ClC1=CC=CC(C=2N=CN=C(C=2)N2C=NC=C2)=C1 DAROHEOKVSJSFA-UHFFFAOYSA-N 0.000 claims description 2
- BXHOWMJGICQXHF-UHFFFAOYSA-N 4-(3-chlorophenyl)-6-pyrazol-1-ylpyrimidine Chemical compound ClC1=CC=CC(C=2N=CN=C(C=2)N2N=CC=C2)=C1 BXHOWMJGICQXHF-UHFFFAOYSA-N 0.000 claims description 2
- PFZSBRMSYRLMCE-UHFFFAOYSA-N 4-(3-fluoro-4-methylphenyl)-6-(2h-tetrazol-5-yl)pyrimidine Chemical compound C1=C(F)C(C)=CC=C1C1=CC(C=2NN=NN=2)=NC=N1 PFZSBRMSYRLMCE-UHFFFAOYSA-N 0.000 claims description 2
- BQTLWRJCOSPNDU-UHFFFAOYSA-N 4-[3-chloro-4-(trifluoromethoxy)phenyl]-6-(2h-tetrazol-5-yl)pyrimidine Chemical compound C1=C(Cl)C(OC(F)(F)F)=CC=C1C1=CC(C=2NN=NN=2)=NC=N1 BQTLWRJCOSPNDU-UHFFFAOYSA-N 0.000 claims description 2
- SBPMGWKYHYKRLR-UHFFFAOYSA-N 4-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-1,3-dihydroimidazol-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(C=2NC(=O)NC=2)=NC=N1 SBPMGWKYHYKRLR-UHFFFAOYSA-N 0.000 claims description 2
- LMJHXFQNUUCRNJ-UHFFFAOYSA-N 4-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-2-methyl-1h-pyrazol-3-one Chemical compound O=C1N(C)NC=C1C1=CC(C=2C=C(Cl)C(Cl)=CC=2)=NC=N1 LMJHXFQNUUCRNJ-UHFFFAOYSA-N 0.000 claims description 2
- OLDJDFWTWFAWRM-UHFFFAOYSA-N 4-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]piperazin-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(N2CC(=O)NCC2)=NC=N1 OLDJDFWTWFAWRM-UHFFFAOYSA-N 0.000 claims description 2
- MVLZWTSKQRHYQE-UHFFFAOYSA-N 4-[6-(3,5-dichlorophenyl)pyrimidin-4-yl]piperazin-2-one Chemical compound ClC1=CC(Cl)=CC(C=2N=CN=C(C=2)N2CC(=O)NCC2)=C1 MVLZWTSKQRHYQE-UHFFFAOYSA-N 0.000 claims description 2
- KIAQGYDLRQLECF-UHFFFAOYSA-N 5-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-1,2-dihydro-1,2,4-triazol-3-one Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(C=2NC(=O)NN=2)=NC=N1 KIAQGYDLRQLECF-UHFFFAOYSA-N 0.000 claims description 2
- PPMMGNWVXQVXGT-UHFFFAOYSA-N 6-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-n-methylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC)=CC=C1C1=CC(C=2C=C(Cl)C(Cl)=CC=2)=NC=N1 PPMMGNWVXQVXGT-UHFFFAOYSA-N 0.000 claims description 2
- BHSBPFTWYYSYDZ-UHFFFAOYSA-N 6-chloro-2-[6-(3-chlorophenyl)pyrimidin-4-yl]-1h-benzimidazole Chemical compound ClC1=CC=CC(C=2N=CN=C(C=2)C=2NC3=CC(Cl)=CC=C3N=2)=C1 BHSBPFTWYYSYDZ-UHFFFAOYSA-N 0.000 claims description 2
- 208000002381 Brain Hypoxia Diseases 0.000 claims description 2
- 201000006474 Brain Ischemia Diseases 0.000 claims description 2
- 206010008027 Cerebellar atrophy Diseases 0.000 claims description 2
- 206010008120 Cerebral ischaemia Diseases 0.000 claims description 2
- 206010012289 Dementia Diseases 0.000 claims description 2
- 206010019196 Head injury Diseases 0.000 claims description 2
- 206010061216 Infarction Diseases 0.000 claims description 2
- 240000007817 Olea europaea Species 0.000 claims description 2
- 208000018737 Parkinson disease Diseases 0.000 claims description 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
- 230000002490 cerebral effect Effects 0.000 claims description 2
- 206010008118 cerebral infarction Diseases 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- 230000007574 infarction Effects 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 2
- 230000007170 pathology Effects 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 125000003107 substituted aryl group Chemical group 0.000 claims description 2
- YGPSJZOEDVAXAB-UHFFFAOYSA-N kynurenine Chemical compound OC(=O)C(N)CC(=O)C1=CC=CC=C1N YGPSJZOEDVAXAB-UHFFFAOYSA-N 0.000 claims 2
- 108090000417 Oxygenases Proteins 0.000 claims 1
- 102000004020 Oxygenases Human genes 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 159000000001 potassium salts Chemical class 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 0 *c1c(*)nc(*)nc1* Chemical compound *c1c(*)nc(*)nc1* 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29809510P | 2010-01-25 | 2010-01-25 | |
| US61/298,095 | 2010-01-25 | ||
| PCT/US2011/021890 WO2011091153A1 (en) | 2010-01-25 | 2011-01-20 | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013518046A JP2013518046A (ja) | 2013-05-20 |
| JP2013518046A5 true JP2013518046A5 (https=) | 2013-12-19 |
Family
ID=44307208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012550116A Pending JP2013518046A (ja) | 2010-01-25 | 2011-01-20 | 特定のキヌレニン−３−モノオキシゲナーゼインヒビターおよびその医薬組成物ならびにこれらの使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8883785B2 (https=) |
| EP (1) | EP2528441A4 (https=) |
| JP (1) | JP2013518046A (https=) |
| KR (1) | KR20120131161A (https=) |
| CN (1) | CN102811620B (https=) |
| AU (1) | AU2011207229B2 (https=) |
| BR (1) | BR112012018500A2 (https=) |
| CA (1) | CA2787365A1 (https=) |
| MX (1) | MX2012008346A (https=) |
| NZ (1) | NZ601547A (https=) |
| PH (1) | PH12012501480A1 (https=) |
| RU (1) | RU2012133475A (https=) |
| SG (1) | SG182534A1 (https=) |
| WO (1) | WO2011091153A1 (https=) |
| ZA (1) | ZA201206223B (https=) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110230428A1 (en) * | 2008-07-22 | 2011-09-22 | John Wityak | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| JP5693452B2 (ja) * | 2008-08-04 | 2015-04-01 | シーエイチディーアイ ファウンデーション，インコーポレーテッド | 特定のキヌレニン−３−モノオキシゲナーゼインヒビター、医薬組成物およびそれらの使用方法 |
| MX2012008346A (es) | 2010-01-25 | 2012-11-12 | Chdi Foundation Inc | Determinados inhibidores de cinurenina-3-monooxigenasa, composiciones farmceuticas y metodos de uso de los mismos. |
| JP2012041325A (ja) * | 2010-08-23 | 2012-03-01 | Bayer Cropscience Ag | オキサジアゾリノン誘導体およびその有害生物の防除用途 |
| RU2576316C2 (ru) | 2010-11-03 | 2016-02-27 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Пестицидная композиция, способ контроля вредителей, способ контроля эндопаразитов, эктопаразитов или обоих и способ усиления жизнестойкости растений |
| EP2651405A2 (en) * | 2010-12-14 | 2013-10-23 | Electrophoretics Limited | Casein kinase 1 (ck1 ) inhibitors |
| CA2841981A1 (en) * | 2011-07-28 | 2013-01-31 | Chdi Foundation, Inc. | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| SI2750677T1 (sl) | 2011-08-30 | 2017-10-30 | Chdi Foundation, Inc. | Inhibitorji kinurenin-3-monooksigenaze, farmacevtski sestavki in postopki njihove uporabe |
| MX2014002459A (es) | 2011-08-30 | 2014-04-10 | Chdi Foundation Inc | Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos. |
| WO2013052526A1 (en) * | 2011-10-06 | 2013-04-11 | Merck Sharp & Dohme Corp. | Triazolyl pde10 inhibitors |
| JP6027128B2 (ja) | 2011-10-26 | 2016-11-16 | ダウ アグロサイエンシィズ エルエルシー | 有害生物防除組成物およびそれに関連した方法 |
| BR122014028247A2 (pt) | 2012-04-27 | 2019-05-07 | Dow Agrosciences Llc | composições pesticidas, processo para controlar praga, uso de uma molécula, processo para aumentar a saúde, rendimento, vigor, qualidade ou tolerância de uma planta e processos para produção de compostos |
| US9708288B2 (en) | 2012-04-27 | 2017-07-18 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
| US9282739B2 (en) | 2012-04-27 | 2016-03-15 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
| CN105209449B (zh) * | 2013-03-14 | 2019-02-01 | 库拉德夫制药私人有限公司 | 犬尿氨酸途径的抑制剂 |
| GB201312800D0 (en) | 2013-07-17 | 2013-08-28 | Heptares Therapeutics Ltd | mGlu5 modulators |
| CA2925952A1 (en) | 2013-10-17 | 2015-04-23 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| EP3057429A4 (en) | 2013-10-17 | 2017-08-09 | Dow AgroSciences LLC | Processes for the preparation of pesticidal compounds |
| US9029554B1 (en) | 2013-10-17 | 2015-05-12 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| JP2016539092A (ja) | 2013-10-17 | 2016-12-15 | ダウ アグロサイエンシィズ エルエルシー | 有害生物防除性化合物の製造方法 |
| MX2016004941A (es) | 2013-10-17 | 2016-06-28 | Dow Agrosciences Llc | Proceso para la preparacion de compuestos plaguicidas. |
| CA2926095A1 (en) | 2013-10-17 | 2015-04-23 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| CA2925953C (en) | 2013-10-17 | 2021-11-02 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| JP2016534073A (ja) | 2013-10-22 | 2016-11-04 | ダウ アグロサイエンシィズ エルエルシー | 相乗的有害生物防除組成物および関連する方法 |
| AR098099A1 (es) | 2013-10-22 | 2016-05-04 | Dow Agrosciences Llc | Composiciones plaguicidas sinérgicas y los métodos relacionados |
| KR20160074628A (ko) | 2013-10-22 | 2016-06-28 | 다우 아그로사이언시즈 엘엘씨 | 상승작용적 살충 조성물 및 관련 방법 |
| AR098100A1 (es) | 2013-10-22 | 2016-05-04 | Dow Agrosciences Llc | Composiciones plaguicidas y los métodos relacionados |
| MX2016005305A (es) | 2013-10-22 | 2017-03-01 | Dow Agrosciences Llc | Composiciones pesticidas sinergicas y metodos relacionados. |
| TW201517797A (zh) | 2013-10-22 | 2015-05-16 | Dow Agrosciences Llc | 協同性殺蟲組成物及相關方法（十一） |
| AU2014340424B2 (en) | 2013-10-22 | 2017-06-29 | Dow Agrosciences Llc | Pesticidal compositions and related methods |
| EP3060044A4 (en) | 2013-10-22 | 2017-04-05 | Dow AgroSciences LLC | Synergistic pesticidal compositions and related methods |
| US9801383B2 (en) | 2013-10-22 | 2017-10-31 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
| US9282740B2 (en) | 2013-10-22 | 2016-03-15 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
| AR098101A1 (es) | 2013-10-22 | 2016-05-04 | Dow Agrosciences Llc | Composiciones plaguicidas y métodos relacionados |
| NZ719952A (en) | 2013-10-22 | 2017-05-26 | Dow Agrosciences Llc | Pesticidal compositions and related methods |
| US9295260B2 (en) | 2013-10-22 | 2016-03-29 | Dow Agrosciences Llc | Pesticidal compositions and related methods |
| NZ719776A (en) | 2013-10-22 | 2017-06-30 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
| RU2656894C2 (ru) | 2013-10-22 | 2018-06-07 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Пестицидные композиции и соответствующие способы |
| JP2016535026A (ja) | 2013-10-22 | 2016-11-10 | ダウ アグロサイエンシィズ エルエルシー | 相乗的有害生物防除組成物および関連する方法 |
| US9788545B2 (en) | 2013-10-22 | 2017-10-17 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
| GB201322512D0 (en) | 2013-12-19 | 2014-02-05 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| JP6633539B2 (ja) | 2014-03-19 | 2020-01-22 | ダウ アグロサイエンシィズ エルエルシー | ２−（２，４−ジフルオロフェニル）−１，１−ジフルオロ−１−（５−置換−ピリジン−２−イル）−３−（１ｈ−テトラゾール−１−イル）プロパン−２−オールおよびその調製工程 |
| CN106715421A (zh) | 2014-07-17 | 2017-05-24 | Chdi基金会股份有限公司 | 用于治疗hiv相关病症的方法和组合物 |
| BR112017000293A2 (pt) | 2014-07-31 | 2017-10-31 | Dow Agrosciences Llc | processo para a preparação de 3-(3-cloro-1h-pirazol-1-il)piridina |
| JP2017523168A (ja) | 2014-07-31 | 2017-08-17 | ダウ アグロサイエンシィズ エルエルシー | ３−（３−クロロ−１ｈ−ピラゾール−１−イル）ピリジンの製造方法 |
| US9249122B1 (en) | 2014-07-31 | 2016-02-02 | Dow Agrosciences Llc | Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine |
| JP2017525703A (ja) | 2014-08-19 | 2017-09-07 | ダウ アグロサイエンシィズ エルエルシー | ３−（３−クロロ−１ｈ−ピラゾール−１−イル）ピリジンの調製方法 |
| AR098113A1 (es) | 2014-09-12 | 2016-05-04 | Dow Agrosciences Llc | Proceso para la preparación de 3-(3-cloro-1h-pirazol-1-il)piridina |
| UA120381C2 (uk) * | 2014-12-19 | 2019-11-25 | Глаксосмітклайн Інтеллектьюел Проперті Девелопмент Лімітед | 3-(6-АЛКОКСИ-5-ХЛОРБЕНЗО[d]ІЗОКСАЗОЛ-3-ІЛ)ПРОПАНОВА КИСЛОТА, ЗАСТОСОВНА ЯК ІНГІБІТОРИ КІНУРЕНІНМОНООКСИГЕНАЗИ |
| GB201508864D0 (en) | 2015-05-22 | 2015-07-01 | Glaxosmithkline Ip Dev Ltd | Compounds |
| GB201508857D0 (en) | 2015-05-22 | 2015-07-01 | Glaxosmithkline Ip Dev Ltd | Compounds |
| BR112019006652A2 (pt) | 2016-10-13 | 2019-07-02 | Juno Therapeutics Inc | métodos e composições para imunoterapia envolvendo moduladores da via metabólica do triptofano |
| ES2959782T3 (es) * | 2016-12-20 | 2024-02-28 | Fmc Corp | Oxadiazoles fungicidas |
| CN110325036B (zh) | 2016-12-29 | 2021-10-26 | 美国陶氏益农公司 | 用于制备杀虫化合物的方法 |
| JP2020503336A (ja) | 2016-12-29 | 2020-01-30 | ダウ アグロサイエンシィズ エルエルシー | 殺有害生物化合物の調製方法 |
| WO2018220762A1 (ja) * | 2017-05-31 | 2018-12-06 | 大塚製薬株式会社 | ピリミジン化合物 |
| WO2019181830A1 (ja) * | 2018-03-19 | 2019-09-26 | 富士フイルム和光純薬株式会社 | 精神疾患の判定方法 |
| JP6870064B2 (ja) * | 2018-11-30 | 2021-05-12 | 大塚製薬株式会社 | ピリミジン化合物の医薬用途 |
| MY210184A (en) | 2018-11-30 | 2025-08-31 | Otsuka Pharma Co Ltd | Heterocyclic compounds for the treatment of epilepsy |
| US11911376B2 (en) | 2020-03-30 | 2024-02-27 | The Regents Of The University Of Colorado | Methods for preventing and treating retinal damage |
| WO2022031946A1 (en) | 2020-08-06 | 2022-02-10 | Chdi Foundation, Inc. | Heterobiaryl compounds and imaging agents for imaging huntingtin protein |
| US12029718B2 (en) | 2021-11-09 | 2024-07-09 | Cct Sciences, Llc | Process for production of essentially pure delta-9-tetrahydrocannabinol |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3707560A (en) * | 1970-10-05 | 1972-12-26 | Pfizer | Certain 4-amino-6-aryl-pyrimidines |
| GB8417852D0 (en) * | 1984-07-13 | 1984-08-15 | Fujisawa Pharmaceutical Co | Pyrimidine derivatives |
| ZA868491B (en) * | 1985-11-09 | 1987-07-29 | Bayer Ag | Nicotinic acid derivatives |
| DE3623302A1 (de) * | 1985-11-09 | 1987-05-14 | Bayer Ag | Nicotinsaeurederivate |
| DE3609596A1 (de) * | 1986-03-21 | 1987-10-01 | Hoechst Ag | 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung |
| MX16687A (es) | 1988-07-07 | 1994-01-31 | Ciba Geigy Ag | Compuestos de biarilo y procedimiento para su preparacion. |
| AU644159B2 (en) * | 1990-05-17 | 1993-12-02 | Novartis Ag | 2-anilino-4-cyanopyrimidine derivatives |
| DE4031798A1 (de) * | 1990-10-08 | 1992-04-09 | Hoechst Ag | Pyridylpyrimidine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als fungizide |
| DE19600934A1 (de) * | 1996-01-12 | 1997-07-17 | Basf Ag | Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung |
| US6610723B2 (en) | 2001-01-29 | 2003-08-26 | Hoffmann-La Roche Inc. | Imidazole derivatives |
| US6552188B2 (en) | 2001-06-29 | 2003-04-22 | Kowa Co., Ltd. | Unsymmetrical cyclic diamine compound |
| AR037233A1 (es) | 2001-09-07 | 2004-11-03 | Euro Celtique Sa | Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento |
| US6949542B2 (en) | 2002-02-06 | 2005-09-27 | Hoffman-La Roche Inc. | Dihydro-benzo[b][1,4]diazepin-2-one derivatives |
| JP2005535710A (ja) | 2002-08-09 | 2005-11-24 | トランス テック ファーマ，インコーポレイテッド | アリールおよびヘテロアリール化合物ならびに凝固を調節する方法 |
| AU2003280558A1 (en) | 2002-10-11 | 2004-05-04 | Kowa Co., Ltd. | Method for treatment of cancer |
| CL2003002353A1 (es) * | 2002-11-15 | 2005-02-04 | Vertex Pharma | Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic |
| CN1747949A (zh) * | 2002-12-20 | 2006-03-15 | 法马西亚公司 | 无环吡唑化合物 |
| WO2004084824A2 (en) * | 2003-03-24 | 2004-10-07 | Merck & Co., Inc. | Biaryl substituted 6-membered heterocyles as sodium channel blockers |
| SE0301963D0 (sv) | 2003-07-02 | 2003-07-02 | Astrazeneca Ab | New compounds |
| JP2007500128A (ja) | 2003-07-25 | 2007-01-11 | アムジエン・インコーポレーテツド | 置換複素環式化合物及び使用方法 |
| JPWO2005040135A1 (ja) | 2003-10-24 | 2007-03-08 | 小野薬品工業株式会社 | 抗ストレス薬およびその医薬用途 |
| CN1890223A (zh) | 2003-10-31 | 2007-01-03 | 神经能质公司 | 辣椒素受体促效剂 |
| DK1763517T3 (da) | 2004-06-28 | 2011-06-06 | Hoffmann La Roche | Pyrimidinderivater som 11beta-HSD1-inhibitorer |
| ATE440820T1 (de) | 2004-08-27 | 2009-09-15 | Astellas Pharma Inc | 2-phenylpyridinderivat |
| JP2008510766A (ja) | 2004-08-27 | 2008-04-10 | ゲーペーツェー ビオテック アーゲー | ピリミジン誘導体 |
| EP1820795A4 (en) | 2004-12-07 | 2010-10-20 | Toyama Chemical Co Ltd | NEW ANTHRANILIC ACID DERIVATIVE OR SALT FROM IT |
| US20060178388A1 (en) * | 2005-02-04 | 2006-08-10 | Wrobleski Stephen T | Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
| US7468383B2 (en) | 2005-02-11 | 2008-12-23 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| ES2400287T3 (es) | 2005-03-14 | 2013-04-08 | High Point Pharmaceuticals, Llc | Derivados de benzazol, composiciones y procedimientos de uso como inhibidores de beta-secretasa |
| EP1910385B1 (en) | 2005-08-04 | 2013-07-24 | Sirtris Pharmaceuticals, Inc. | Benzothiazoles and thiazolopyridines as sirtuin modulators |
| EP1912970A2 (en) | 2005-08-10 | 2008-04-23 | Bayer Schering Pharma Aktiengesellschaft | Acyltryptophanols for fertility control |
| WO2007024922A1 (en) | 2005-08-23 | 2007-03-01 | Irm Llc | Immunosuppressant compounds and compositions |
| TW200745055A (en) * | 2005-09-23 | 2007-12-16 | Organon Nv | 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| JP2009518442A (ja) | 2005-12-05 | 2009-05-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 可溶性エポキシド加水分解酵素インヒビターとして有益な置換ピラゾール化合物 |
| AU2006325746A1 (en) | 2005-12-14 | 2007-06-21 | Bristol-Myers Squibb Company | Six-membered heterocycles useful as serine protease inhibitors |
| US7951824B2 (en) | 2006-02-17 | 2011-05-31 | Hoffman-La Roche Inc. | 4-aryl-pyridine-2-carboxyamide derivatives |
| JP2007230963A (ja) | 2006-03-03 | 2007-09-13 | Daiso Co Ltd | ２，４−ジ置換ピリジンの製造法 |
| JP5151045B2 (ja) * | 2006-03-13 | 2013-02-27 | コニカミノルタホールディングス株式会社 | 有機エレクトロルミネッセンス素子、表示装置及び照明装置 |
| BRPI0713350B1 (pt) | 2006-06-26 | 2022-04-12 | Akebia Therapeutics Inc | Composto, e, composição |
| EP2420494B1 (en) * | 2006-08-16 | 2014-10-08 | The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone | Use of thiadiazole compounds as inhibitors of kynurenine-3-monooxygenase |
| DK2054397T3 (en) * | 2006-08-16 | 2016-01-18 | J David Gladstone Inst A Testamentary Trust Established Under The Will Of J David Gladstone | SMALL MOLECULAR INHIBITORS OF KYNURENIN-3-MONOOXYGENASE |
| US20110172230A1 (en) | 2006-08-23 | 2011-07-14 | Takahiro Ishii | Urea compound or salt thereof |
| US8188113B2 (en) | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| JP2008074751A (ja) * | 2006-09-20 | 2008-04-03 | Taiho Yakuhin Kogyo Kk | フェニルピリミジン化合物又はその塩、及びその用途 |
| JP2008218986A (ja) * | 2007-02-06 | 2008-09-18 | Sumitomo Chemical Co Ltd | 組成物及び該組成物を用いてなる発光素子 |
| WO2008095852A1 (en) | 2007-02-08 | 2008-08-14 | Respiratorius Ab | Bronchorelaxing arylamides |
| EP2142498A2 (en) | 2007-04-02 | 2010-01-13 | Institute for Oneworld Health | Cftr inhibitor compounds and uses thereof |
| EP2002834A1 (de) | 2007-06-13 | 2008-12-17 | Bayer Schering Pharma Aktiengesellschaft | Aryl/Hetarylamide als Modulatoren des EP2-Rezeptors |
| AR067354A1 (es) | 2007-06-29 | 2009-10-07 | Sunesis Pharmaceuticals Inc | Compuestos utiles como inhibidores de la raf quinasa |
| TW200924778A (en) * | 2007-10-10 | 2009-06-16 | Takeda Pharmaceutical | Amide compound |
| PE20091309A1 (es) | 2007-12-21 | 2009-09-30 | Astrazeneca Ab | Derivados de ciclohexilo como inhibidores de acetil coenzima a carboxilasa |
| JP2009280521A (ja) | 2008-05-22 | 2009-12-03 | Daiso Co Ltd | ２，４−ジ置換ピリジンの製造法 |
| JP2011184298A (ja) | 2008-06-02 | 2011-09-22 | Sanwa Kagaku Kenkyusho Co Ltd | 新規化合物及びその医薬用途 |
| JP2011527677A (ja) | 2008-07-08 | 2011-11-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｎｈｅ−１阻害剤として有用なピロリジニル及びピペリジニル化合物 |
| JP5693452B2 (ja) | 2008-08-04 | 2015-04-01 | シーエイチディーアイ ファウンデーション，インコーポレーテッド | 特定のキヌレニン−３−モノオキシゲナーゼインヒビター、医薬組成物およびそれらの使用方法 |
| WO2010064597A1 (ja) * | 2008-12-01 | 2010-06-10 | 武田薬品工業株式会社 | ピペリジン誘導体 |
| WO2010100475A1 (en) | 2009-03-02 | 2010-09-10 | Astrazeneca Ab | Hydroxamic acid derivatives as gram-negative antibacterial agents |
| KR101675607B1 (ko) | 2009-04-07 | 2016-11-11 | 에머리티 파마 아베 | 치료제로서 이소옥사졸-3(2ｈ)-온 유사체 |
| US20120041009A1 (en) * | 2009-05-18 | 2012-02-16 | Sumitomo Chemical Company, Limited | Pyrimidine compound and its use in pest control |
| TWI491606B (zh) | 2009-07-13 | 2015-07-11 | Gilead Sciences Inc | 調節細胞凋亡信號之激酶的抑制劑 |
| US8859776B2 (en) | 2009-10-14 | 2014-10-14 | Merck Sharp & Dohme Corp. | Substituted piperidines that increase p53 activity and the uses thereof |
| WO2011050323A1 (en) | 2009-10-22 | 2011-04-28 | The Washington University | Compounds and methods for treating bacterial infections |
| MX2012008346A (es) | 2010-01-25 | 2012-11-12 | Chdi Foundation Inc | Determinados inhibidores de cinurenina-3-monooxigenasa, composiciones farmceuticas y metodos de uso de los mismos. |
| EA023221B1 (ru) | 2010-02-27 | 2016-05-31 | Байер Интеллектуэль Проперти Гмбх | СВЯЗАННЫЕ БИС-АРИЛЬНЫЕ АРИЛ-ТРИАЗОЛОНЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ИХ ПРИМЕНЕНИЕ, ЛЕКАРСТВЕННОЕ СРЕДСТВО НА ИХ ОСНОВЕ И ДВОЙНОЙ АНТАГОНИСТ V1a/V2-РЕЦЕПТОРОВ |
| SI2588475T1 (sl) | 2010-07-02 | 2015-12-31 | Gilead Sciences, Inc. | Kinazni inhibitorji za regulacijo apoptoznega signala |
| EP2616441B1 (en) | 2010-09-17 | 2019-08-07 | Purdue Pharma L.P. | Pyridine compounds and the uses thereof |
-
2011
- 2011-01-20 MX MX2012008346A patent/MX2012008346A/es not_active Application Discontinuation
- 2011-01-20 KR KR1020127021570A patent/KR20120131161A/ko not_active Withdrawn
- 2011-01-20 EP EP11735184.1A patent/EP2528441A4/en not_active Withdrawn
- 2011-01-20 CA CA2787365A patent/CA2787365A1/en not_active Abandoned
- 2011-01-20 RU RU2012133475/04A patent/RU2012133475A/ru not_active Application Discontinuation
- 2011-01-20 NZ NZ601547A patent/NZ601547A/en not_active IP Right Cessation
- 2011-01-20 CN CN201180015784.XA patent/CN102811620B/zh not_active Expired - Fee Related
- 2011-01-20 WO PCT/US2011/021890 patent/WO2011091153A1/en not_active Ceased
- 2011-01-20 SG SG2012052189A patent/SG182534A1/en unknown
- 2011-01-20 JP JP2012550116A patent/JP2013518046A/ja active Pending
- 2011-01-20 US US13/575,019 patent/US8883785B2/en active Active
- 2011-01-20 AU AU2011207229A patent/AU2011207229B2/en not_active Expired - Fee Related
- 2011-01-20 BR BR112012018500A patent/BR112012018500A2/pt not_active IP Right Cessation
- 2011-01-20 PH PH1/2012/501480A patent/PH12012501480A1/en unknown
-
2012
- 2012-08-17 ZA ZA2012/06223A patent/ZA201206223B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013518046A5 (https=) | ||
| RU2012133475A (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| JP2007523182A5 (https=) | ||
| RU2506267C2 (ru) | Бензопирановые и бензоксепиновые ингибиторы рi3k и их применение | |
| JP2014517833A5 (https=) | ||
| JP2015172062A5 (https=) | ||
| JP2018535999A5 (https=) | ||
| IL187690A (en) | Derivatives 1, 2, 4 - Triazolo - 1, 6 - Naphthiridines as inhibitors of AKT activity for use in the preparation of drugs for the treatment of cancer | |
| JP2006503009A5 (https=) | ||
| JP2014517069A5 (https=) | ||
| JP2015533157A5 (https=) | ||
| SI2981533T1 (en) | Protein Protein Kinase | |
| JP2007523208A5 (https=) | ||
| RU2006127573A (ru) | Соединения тетразола и их применение в качестве антагонистов метаботропного рецептора глутамата | |
| RU2009147733A (ru) | Пиридилпиперидновые антагонисты рецептора орексинов | |
| HRP20161396T1 (hr) | Derivati 2-(fenil ili pirid-3-il)aminopirimidina kao modulatori lrrk2-kinaze za liječenje parkinsonove bolesti | |
| JP2014525444A5 (https=) | ||
| AR072201A1 (es) | 2-arilaminoquinazolinas para el tratamiento de enfermedades proliferativas | |
| CA2494987A1 (en) | Isoxazoles and their use as modulators of metabotropic glutamate receptor-5 | |
| JP2009525340A5 (https=) | ||
| JP2009534386A5 (https=) | ||
| RU2018143324A (ru) | Применение 1H-пиразоло[4,3-b]пиридинов в качестве ингибиторов PDE1 | |
| JP2010513272A5 (https=) | ||
| ME02437B (me) | Disupstituirani oktahidropirolo[3,4-c]piroli kao modulatori oreksin receptora | |
| JP2017528504A5 (https=) |